Pacific Biosciences
PACB
$7.56
Share price
13.51%
Change (1 day)
-77.16%
Change (1 year)
Revenue for Pacific Biosciences (PACB)
Revenue in 2022 (TTM): $0.13 B
According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2021 the company made a revenue of $0.13 B an increase over the years 2020 revenue that were of $0.07 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Pacific Biosciences from 2010 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.13 B | 6.92% |
| 2021 | $0.13 B | 65.43% |
| 2020 | $0.07 B | -13.2% |
| 2019 | $0.09 B | 15.6% |
| 2018 | $0.07 B | -15.88% |
| 2017 | $0.09 B | 3.04% |
| 2016 | $0.09 B | -2.23% |
| 2015 | $0.09 B | 53.12% |
| 2014 | $0.06 B | 115.02% |
| 2013 | $0.02 B | 8.46% |
| 2012 | $0.02 B | -23.27% |
| 2011 | $0.03 B | 1922.88% |
| 2010 | $1.67 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $42.82 B | 30,585.22% | 🇺🇸 USA |
 General Electric GE | $74.48 B | 53,275.23% | 🇺🇸 USA |
 Illumina ILMN | $4.65 B | 3,236.53% | 🇺🇸 USA |
 PerkinElmer
PKI | $5.02 B | 3,497.39% | 🇺🇸 USA |
 Luminex LMNX | N/A | -100.00% | 🇺🇸 USA |
 NanoString Technologies NSTG | $0.14 B | 3.58% | 🇺🇸 USA |